Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Ranimustine

Home DrugsRanimustine

Experimental

Small Molecule

Ranimustine

Unknown Manufacturer

Generate AI report

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Indications

用于成年人胶质细胞瘤、骨髓瘤、恶性淋巴瘤、慢性骨髓性白血病及血小板增多症等。

Technical identifiers

Chemical Formula: C₁₀H₁₈ClN₃O₇
CAS Number: 58994-96-0
UNII ID: RYH2T97J77

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

Anticancer composition containing ranimustine
Applicant: JINAN KANGQUAN MEDICINE SCI TEPriority: 2007
CN
Medicinal composition comprising active components of 5-HT 3 receptor antagonist and H2 receptor antagonist and use thereof
Applicant: UNIV CHINA PHARMAPriority: 2006
CN
An anticancer sustained release injection carrying tumor drug resistance reversal agent and cytotoxic drug simultaneously
Applicant: JINAN KANGQUAN PHARMACEUTICALPriority: 2006
CN
A sustained release injection carrying clorfarabine and cytotoxic drug
Applicant: JINAN KANGQUAN PHARMACEUTICALPriority: 2006
CN
Sustained-release gel injection loaded with platinum compound and alkyl agent
Applicant: JINAN JIFU MEDICINE SCIENCE ANPriority: 2008
CN
Sustained release anticancer agent carrying angiogenesis inhibitor and cytotoxic drug
Applicant: JINAN KANGQUAN PHARMACEUTICALPriority: 2006
CN
Anticancer sustained-released gel injection and preparation method thereof
Applicant: JINAN JIFU MEDICINE SCIENCE ANPriority: 2008
CN
Slow release injection containing blood vessel inhibitor and cell toxicant medicine
Applicant: JINAN KANGQUAN MEDICINE TECHNOPriority: 2006
CN